Biomarkers for cancer cachexia: where do we stand?
作者信息
Palus Sandra, Springer Jochen
机构信息
Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin, Berlin, Germany.
German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
出版信息
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1388-1389. doi: 10.1002/jcsm.12641. Epub 2020 Nov 30.
Abstract
摘要
相似文献
1
Biomarkers for cancer cachexia: where do we stand?癌症恶病质的生物标志物：我们目前的进展如何？
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1388-1389. doi: 10.1002/jcsm.12641. Epub 2020 Nov 30.
2
Cancer cachexia: Diagnosis, assessment, and treatment.癌症恶病质：诊断、评估与治疗。
Crit Rev Oncol Hematol. 2018 Jul;127:91-104. doi: 10.1016/j.critrevonc.2018.05.006. Epub 2018 May 31.
3
'Pre-cachexia': a non-existing phenomenon in cancer?“癌前恶病质”：癌症中一种并不存在的现象？
Ann Oncol. 2014 Aug;25(8):1668-9. doi: 10.1093/annonc/mdu178. Epub 2014 May 14.
4
Malignancy. Cancer cachexia.恶性肿瘤。癌症恶病质。
Br J Hosp Med. 1982 Jan;27(1):28-9, 33-4.
5
The conundrum of pre-cachexia existence.恶病质前期存在的难题。
Clin Nutr. 2014 Dec;33(6):1160. doi: 10.1016/j.clnu.2014.09.024.
6
Cancer cachexia, recent advances, and future directions.癌症恶病质、最新进展及未来方向。
Cancer J. 2015 Mar-Apr;21(2):117-22. doi: 10.1097/PPO.0000000000000100.
7
Meaningful measures in cancer cachexia: implications for practice and research.癌症恶病质的有意义指标：对实践和研究的启示
Curr Opin Support Palliat Care. 2019 Dec;13(4):323-327. doi: 10.1097/SPC.0000000000000472.
8
Casting the net broader to confirm our imaginations: the long road to treating wasting disorders.广泛撒网以验证我们的设想：治疗消耗性疾病的漫漫征途。
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):870-880. doi: 10.1002/jcsm.12256.
9
Favorable responses to tocilizumab in two patients with cancer-related cachexia.两名癌症相关性恶病质患者对托珠单抗治疗反应良好。
J Pain Symptom Manage. 2013 Aug;46(2):e9-e13. doi: 10.1016/j.jpainsymman.2013.01.009. Epub 2013 Apr 17.
10
Measuring cachexia-diagnostic criteria.测量恶病质诊断标准。
Ann Palliat Med. 2019 Jan;8(1):24-32. doi: 10.21037/apm.2018.08.07. Epub 2018 Sep 7.
引用本文的文献
1
Multi-omics characterization of cachexia-related genes reveals prognostic signatures and immune landscape in breast cancer.恶病质相关基因的多组学特征揭示了乳腺癌的预后特征和免疫格局。
Clin Transl Oncol. 2025 Aug 29. doi: 10.1007/s12094-025-04025-6.
2
Combating chronic kidney disease-associated cachexia: A literature review of recent therapeutic approaches.对抗慢性肾脏病相关性恶病质：近期治疗方法的文献综述
BMC Nephrol. 2025 Mar 11;26(1):133. doi: 10.1186/s12882-025-04057-8.
3
Longitudinal Muscle Biopsies Reveal Inter- and Intra-Subject Variability in Cancer Cachexia: Paving the Way for Biopsy-Guided Tailored Treatment.纵向肌肉活检揭示癌症恶病质患者个体间和个体内的变异性：为活检引导的个体化治疗铺平道路。
Cancers (Basel). 2024 Mar 6;16(5):1075. doi: 10.3390/cancers16051075.
本文引用的文献
1
High levels of modified ceramides are a defining feature of murine and human cancer cachexia.高水平的修饰神经酰胺是鼠类和人类恶病质的一个明确特征。
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1459-1475. doi: 10.1002/jcsm.12626. Epub 2020 Oct 8.
2
Evaluation of Nutritional, Inflammatory, and Fatty Acid Status in Patients with Gastric and Colorectal Cancer Receiving Chemotherapy.评估接受化疗的胃癌和结直肠癌患者的营养、炎症和脂肪酸状况。
Nutr Cancer. 2021;73(3):420-432. doi: 10.1080/01635581.2020.1756351. Epub 2020 Apr 28.
3
Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients.比较杜氏肌营养不良症和贝克肌营养不良症肌肉的蛋白质组学分析：导致贝克肌营养不良症患者肌肉功能得以保留的变化。
J Cachexia Sarcopenia Muscle. 2020 Apr;11(2):547-563. doi: 10.1002/jcsm.12527. Epub 2020 Jan 28.
4
Identification of microRNAs in skeletal muscle associated with lung cancer cachexia.鉴定与肺癌恶病质相关的骨骼肌中的 microRNAs。
J Cachexia Sarcopenia Muscle. 2020 Apr;11(2):452-463. doi: 10.1002/jcsm.12512. Epub 2019 Dec 11.
5
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019.《恶病质、肌少症与肌肉杂志》发表伦理准则：2019 年更新版。
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1143-1145. doi: 10.1002/jcsm.12501.
6
Switching on the furnace: Regulation of heat production in brown adipose tissue.开启熔炉：棕色脂肪组织产热的调节。
Mol Aspects Med. 2019 Aug;68:60-73. doi: 10.1016/j.mam.2019.07.005. Epub 2019 Aug 5.
7
Macrophages protect against loss of adipose tissue during cancer cachexia.巨噬细胞在癌症恶病质期间保护脂肪组织免于损失。
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1128-1142. doi: 10.1002/jcsm.12450. Epub 2019 Jul 18.
8
Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa.癌症恶病质导致肠道黏膜发生形态和炎症改变。
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1116-1127. doi: 10.1002/jcsm.12449. Epub 2019 Jul 15.
9
The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.胰腺癌的系统性激活素反应：对有效癌症恶病质治疗的启示。
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1083-1101. doi: 10.1002/jcsm.12461. Epub 2019 Jul 8.
10
Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.肿瘤衍生的转化生长因子-β信号通路促进癌症恶病质患者的纤维化。
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1045-1059. doi: 10.1002/jcsm.12441. Epub 2019 Jul 4.
Zotero 插件